EIDP, Inc.
NYSE:CTA-PAAgricultural Inputs
+$0.38 today
- Market cap
- $41.74B
- Beta
- 0.04
- P/E (TTM)
- 22.5
- EPS (TTM)
- $0.00
- Dividend yield
- 6.67%
Volume 0.00M
Average 0.00M
CTA-PA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
EIDP, Inc.NYSE: CTA-PA
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $397M rose 13.1% year over year, ahead of the +7.9% change in trailing-twelve-month research & development. Sequentially, it rose 2.3% from the prior quarter. Over 3 fiscal years it compounded at +6.6% a year.
Context
- Research & development amounted to 8.5% of revenue in FY2025, up 0.2 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +13.1% holds above the trailing-twelve-month pace of +7.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 1.47B USD
- Year-over-year change
- +5.1%
- 4-year CAGR
- +5.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.47B | +5.1% |
| FY2024 | 2024-12-31 | 1.4B | +4.9% |
| FY2023 | 2023-12-31 | 1.34B | +10.0% |
| FY2022 | 2022-12-31 | 1.22B | +2.4% |
| FY2021 | 2021-12-31 | 1.19B | — |
Research & Development vs competitors
How CTA-PA compares with its peers on the latest reported figures
- CTA-PA's LTM Sep 2026 research & development of $1.54B is the highest of the 8 companies compared; the peer median is $59M.
- Its year-over-year change of +7.9% is the highest of 5, against a peer median of -0.5%.
- Research & development amounts to 8.7% of revenue for CTA-PA, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.54B | +7.9% | +6.6% | 8.7% | |
| LTM Sep 2026 | $1.54B | +7.9% | +6.6% | 8.7% | |
VYLRVylor Inc. | FY2025 | $979M | +7.0% | — | 9.7% |
| LTM Mar 2026 | $262.9M | -8.0% | -5.4% | 7.7% | |
| LTM Sep 2026 | $59M | -18.1% | +1.0% | 0.8% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CTA-PA) | $59M | -0.5% | +1.0% | 0.8% | |
Competitors are the stored peer set for CTA-PA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 15.66B | 17.46B | 17.23B | 16.91B | 17.4B |
| Cost of Revenue | 9.22B | 10.44B | 9.92B | 9.53B | 9.17B |
| Gross Profit | 6.44B | 7.02B | 7.31B | 7.38B | 8.23B |
| Gross Margin | 41.1% | 40.2% | 42.4% | 43.6% | 47.3% |
| Research & Development | 1.19B | 1.22B | 1.34B | 1.4B | 1.47B |
| Selling, General & Admin | 3.21B | 3.17B | 3.18B | 3.2B | 3.49B |
| Operating Expenses | 5.12B | 5.09B | 5.2B | 5.28B | 5.61B |
| Depreciation & Amortization | 1.24B | 1.22B | 1.21B | 1.23B | 1.2B |
| EBITDA | 3.62B | 2.73B | 2.54B | 2.74B | 3.07B |
| EBITDA Margin | 23.1% | 15.6% | 14.7% | 16.2% | 17.6% |
| Operating Income | 1.32B | 1.93B | 2.11B | 2.1B | 2.62B |
| Operating Margin | 8.4% | 11.0% | 12.2% | 12.4% | 15.1% |
| Interest Income | 77M | 124M | 283M | 132M | 136M |
| Interest Expense | 30M | 79M | 233M | 233M | 180M |
| Other Income / Expenses | 1.03B | (502M) | (1.02B) | (821M) | (931M) |
| Income Before Tax | 2.35B | 1.43B | 1.09B | 1.28B | 1.69B |
| Pre-Tax Margin | 15.0% | 8.2% | 6.3% | 7.5% | 9.7% |
| Income Tax Expense | 524M | 210M | 152M | 412M | 484M |
| Net Income | 1.76B | 1.15B | 735M | 907M | 1.09B |
| Net Margin | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| EPS (Basic) | 0.02 | 0.00 | 0.84 | 1.31 | 1.60 |
| EPS (Diluted) | 0.02 | 0.00 | 0.84 | 1.30 | 1.60 |
| Weighted Avg Shares | 749.5M | 0 | 867.81M | 867.81M | 0 |
| Weighted Avg Shares (Diluted) | 749.5M | 0 | 867.81M | 867.81M | 0 |
EIDP, Inc.
NYSE:CTA-PA
Intrinsic Alpha fair value
Locked
Current Price
$43.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.